Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

Subjects:

Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

Subjects:

Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

Subjects:

Clinical outcomes at 1-year. by Erika Yamamoto (3809308)

Subjects:

Bendamustine treatment of haematological malignancies: significant risks of opportunistic viral, fungal and bacterial infections by Tony K.Y. Wu (12531048)

“…Age remained the only significant risk on multivariate analysis. CMV reactivation resulted in retinitis (<i>N</i> = 4), ependymitis/ventriculitis (<i>N</i> = 1) and duodenitis/colitis (<i>N</i> = 1). …”

Risk of bias summary. by Manuela Llano-León (14599800)

Clinical characteristics of the study population. by Hun Gi Lee (21526538)

“…After adjustment, the risk of emergency surgery did not show a statistically significant difference, but the risk of ICU admission and unfavorable outcomes increased. …”

Table_1_Differences and Similarities in Motives to Decrease Drinking, and to Drink in General Between Former and Current Heavy Drinkers—Implications for Changing Own Drinking Behav... by Magdalena Rowicka (11935229)

“…Additionally, a set of questions regarding motives to decrease drinking were analysed. The results show that differences were observed between the investigated groups: the current dependent group scored significantly higher on all the dimensions of drinking motives than the current low-risk group and significantly higher on coping, social, and enhancement motives than former heavy drinkers (both groups). …”

The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin... by Chanel Avenant (409756)

“…Any within or between contraceptive group androgenic effects on behavior in the brain are likely dominated by the androgenic activities of MPA and NET and not by the decreased endogenous testosterone levels. The clinical trial was registered with the Pan African Clinical Trials Registry (PACTR 202009758229976)</p>…”

Demographic, clinical, and densitometric characteristics of study participants. by Agnieszka Budnik (17241045)

Subjects:

Clinical baseline data after PSM. by Jie Zhao (49409)

Subjects:

Baseline data of clinical ICU patients. by Jie Zhao (49409)

Subjects:

Adjusted in-hospital clinical outcomes associated with left atrial appendage occlusion utilization during valvular heart surgery. by Ayesha P. Ng (15909876)

Subjects:

Kaplan-Meier curves for time until depression/anxiety stratified by OM, WLR, and WLM. by G. Craig Wood (7522025)

Subjects:

Overview of study design and timeline. by G. Craig Wood (7522025)

Subjects:

Kaplan-Meier curves for time until cancer stratified by sex and OM, WLR, and WLM. by G. Craig Wood (7522025)

Subjects:

Poisson Regression for days with healthcare utilization visits per year compared within Weight Loss Maintainers. by G. Craig Wood (7522025)

Subjects:

Baseline descriptive statistics of the study population. by G. Craig Wood (7522025)

Subjects: